NCT04410029

Brief Summary

This study aims to determine the effect of the Healthwise decision aid on shared decision making in women undergoing management of early pregnancy loss.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 1, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

July 29, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2021

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2021

Completed
Last Updated

March 29, 2021

Status Verified

March 1, 2021

Enrollment Period

8 months

First QC Date

May 18, 2020

Last Update Submit

March 26, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Decision Conflict Scale (DCS)

    Low-literacy version of Decision Conflict Scale

    Post-counseling (one day)

Study Arms (2)

Intervention

EXPERIMENTAL

Standard counseling + Healthwise Decision Aid

Other: Healthwise Decision Aid

Control

ACTIVE COMPARATOR

Standard counseling + a control informational handout.

Other: Control informational handout

Interventions

Healthwise, a non-profit company that develops health content and patient information for hospitals, has created a decision aid for EPL management that is available through the EPIC Systems, an electronic medical record. Participants will be given this decision aid after EPL diagnosis and prior to options consultation with a provider.

Intervention

Participants randomized to the control arm will be given an informational handout of treatment options after EPL diagnosis and prior to options consultation with a provider.

Control

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speaking
  • Definitive diagnosis of early intrauterine pregnancy loss (including anembryonic pregnancy and missed abortion \[ultrasound examination demonstrates fetal pole without cardiac activity measuring between 5.3 and 7mm or an abnormal growth pattern diagnostic of EPL\])
  • years or older
  • Willing and able to give informed consent

You may not qualify if:

  • Pregnancy of unknown anatomic location
  • Unable to read English
  • Prior options counseling with a Family Planning provider
  • Clinically unstable requiring emergent surgical management with uterine evacuation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19143, United States

Location

MeSH Terms

Conditions

Abortion, Spontaneous

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2020

First Posted

June 1, 2020

Study Start

July 29, 2020

Primary Completion

March 23, 2021

Study Completion

March 25, 2021

Last Updated

March 29, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations